Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial investigating gemcitabine hydrochloride, cisplatin, and temsirolimus as first-line therapy for locally advanced or metastatic urothelial cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: Cardiff University | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 1, Phase 2 | Status: COMPLETED